热门资讯> 正文
MEI Pharma GAAP EPS of -$0.12
2025-11-17 22:13
- MEI Pharma press release (LITS): Q1 GAAP EPS of -$0.12.
- As of September 30, 2025, we had $10.1 million in cash and cash equivalents and $99.4 million in digital assets.
More on MEI Pharma
- Lite Strategy: From Biotech To Litecoin Treasury
- Seeking Alpha’s Quant Rating on MEI Pharma
- Financial information for MEI Pharma
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。